Abstract
The relationship between phenytoin-induced ataxia and its concentration was characterized in rats who received i.v. infusions of the drug at either 0.52, 0.85 or 1.70 mg/min/rat until the onset of ataxia. Phenytoin dose to ataxia did not change with infusion rate but the total and unbound serum concentrations at onset of ataxia increased with increasing infusion (input) rate. Concentrations in cerebrospinal fluid, CSF, and in brain, at this end-point, were not affected by the infusion rate. Direct i.v. infusion of phenytoin major metabolite, p- HPPH , failed to produce ataxia. Thus phenytoin in CSF and brain, unlike serum phenytoin, equilibrates rapidly with site(s) of phenytoin neurotoxicity and represents appropriate sampling sites for identifying factors affecting phenytoin neurotoxicity.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
